CUE
Cue Biopharma, Inc.stockNASDAQ
Market OpenNov 18, 2026 1:11:49 PM EST
4.12USD+45.583%(+1.29)10,561,232
Pre-marketNov 18, 2026 9:29:30 AM EST
3.2902USD+16.261%(+0.4602)
CUE Financials
In Q3 FY 2026 (ended ), Cue Biopharma, Inc. (CUE) reported revenue of $132K, net income of −$50.02M, operating cash flow of −$10.08M, and assets of $67.26M (filed ).
Loading financial statements…
